Search Results - Stephanie Roberson

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    LY2439821, a humanized anti–interleukin‐17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double‐blind, placebo‐controlled, proof‐of‐concept study

    LY2439821, a humanized anti–interleukin‐17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double‐blind, placebo‐controlled, proo... by Mark C. Genovese, Filip Van den Bosch, Stephanie Roberson, S. Bojin, Ilaria Biagini, P. F. J. Ryan, J Sloan-Lancaster

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study

    Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell... by Ravi Salgia, R Weaver, Michael McCleod, John R. Stille, S. Betty Yan, Stephanie Roberson, John Polzer, Amy Flynt, Eyas Raddad, Victoria L. Peek, Sameera R. Wijayawardana, Suzane L. Um, Steve Gross, Mark C. Connelly, Carrie Morano, Madeline Repollet, Renouard Sanders, Kurt Baeten, David D’Haese, David R. Spigel

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: